**Core Concept**
Spectinomycin, a poorly absorbed antibiotic, targets bacterial protein synthesis by binding to the 30S ribosomal subunit, distinct from the mechanism of action of beta-lactam antibiotics that inhibit cell wall synthesis. This principle is crucial for understanding the pharmacological differences among various antibiotic classes.

**Why the Correct Answer is Right**
Spectinomycin specifically inhibits protein synthesis by binding to the 30S ribosomal subunit, disrupting bacterial protein production. This is in contrast to beta-lactam antibiotics, which inhibit cell wall synthesis by binding to penicillin-binding proteins (PBPs) or inhibit the synthesis of peptidoglycan, a critical component of the bacterial cell wall. The mechanism of action of spectinomycin does not involve cell wall synthesis, making it distinct from other antibiotics that target this process.

**Why Each Wrong Option is Incorrect**
**Option B:** Vancomycin is a glycopeptide antibiotic that inhibits cell wall synthesis by binding to the D-alanyl-D-alanine terminus of the peptidoglycan precursor, preventing its incorporation into the bacterial cell wall. This action is characteristic of cell wall inhibitors.
**Option C:** Aztreonam is a monobactam antibiotic that inhibits cell wall synthesis by binding to PBPs, similar to other beta-lactam antibiotics. This mechanism of action is distinct from spectinomycin's protein synthesis inhibition.
**Option D:** Cephalexin is a cephalosporin antibiotic that inhibits cell wall synthesis by binding to PBPs, disrupting peptidoglycan synthesis and bacterial cell wall integrity. This action is characteristic of beta-lactam antibiotics.

**Clinical Pearl / High-Yield Fact**
When choosing an antibiotic, it is essential to consider the mechanism of action, spectrum of activity, and potential for resistance development. This knowledge helps guide antibiotic selection and minimize the risk of treatment failure.

**✓ Correct Answer: A. Spectinomycin. Spectinomycin inhibits bacterial protein synthesis.**